26 min listen
Former CMO Brian Levy Sits in the CEO Chair to Lead OcuNexus Down a Bold, New Biopharma Path
Former CMO Brian Levy Sits in the CEO Chair to Lead OcuNexus Down a Bold, New Biopharma Path
ratings:
Length:
44 minutes
Released:
Feb 20, 2019
Format:
Podcast episode
Description
Former Aerie CMO Brian Levy, OD, was settling down for a quieter life in Florida when he came upon OcuNexus, a biopharmaceutical company utilizing a novel mechanism of action called “Gap Junction Channel Modulation” to develop treatments for the front and back of the eye. Levy saw the opportunity to create a biopharma capable of devising new therapies inside and outside of ophthalmology.
Released:
Feb 20, 2019
Format:
Podcast episode
Titles in the series (100)
Mazzo Muses on the FDA, Google and Failing Fast by OIS Podcast | Ophthalmology's leading Podcast